Mechanisms of Pesticide-Induced Neurobehavioral Deficits: Relevance to ADHD
农药引起的神经行为缺陷的机制:与多动症的相关性
基本信息
- 批准号:7337586
- 负责人:
- 金额:$ 55.77万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-09-01 至 2012-06-30
- 项目状态:已结题
- 来源:
- 关键词:Adverse effectsAffectAmphetaminesAnimal ModelAttentionAttention deficit hyperactivity disorderBehaviorBehavioralBehavioral ParadigmChildClinicalComplementComplexDataDevelopmentDiseaseDopaminergic CellDoseEmbryoEnvironmental Risk FactorEtiologyExhibitsFemaleFunctional disorderGenderGenesGeneticGenetic PolymorphismHyperactive behaviorImpulsivityIncidenceLaboratoriesLeadLinkMediatingMethylphenidateModelingMolecularMolecular TargetMusNeuronsNuclearOutcomePatientsPesticidesPregnant WomenRNA InterferenceResearch PersonnelRisk FactorsRoleSchool-Age PopulationSeveritiesSex CharacteristicsSignal TransductionSymptomsTechniquesTestingTherapeutic AgentsTherapeutic InterventionUnited States Environmental Protection AgencyViraldecamethrindopamine systemdopamine transportergender preferencegene environment interactionimprovedin uteroin vivoinsightmaleneurobehavioralneurochemistrynovelpesticide exposureprogramspsychostimulantpyrethroidresponsetranscription factor
项目摘要
DESCRIPTION (provided by applicant):
Attention-deficit hyperactivity disorder (ADHD) is a clinically heterogeneous disorder characterized by core features of impulsivity, hyperactivity, and attention deficits. ADHD is estimated to affect 8-12% of
school-aged children worldwide. ADHD is a complex disorder with significant genetic contributions.
However, no single gene has been linked to a significant percentage of cases, suggesting that
environmental factors or gene-environment interactions may contribute to the etiology or clinical
manifestation of ADHD. Dopamine transporter (DAT) polymorphisms and elevated expression of the DAT have been observed in ADHD patients, suggesting alterations in DAT levels may contribute to ADHD. Since environmental factors, such as pesticides, have been shown to alter DAT expression, we have hypothesized that in utero pesticide exposure may contribute to the incidence or severity of ADHD. Recent data from this laboratory have demonstrated that the offspring of mice exposed to low levels of the pyrethroid pesticide deltamethrin during development exhibit similar symptoms as observed in children with ADHD, including elevated DAT levels, hyperactivity, a paradoxical calming response to psychostimulants, behavioral deficits, and a male gender-preference of these effects. Importantly, the doses that elicited these effects were at or below the no observable adverse effect level (NOAEL) established by the EPA for deltamethrin. This is particularly notable because the NOAEL used by the EPA when making regulatory decisions on pesticides. Because there has been documented exposure of pregnant women to pyrethroids and pyrethroid use has increased dramatically in the last decade, it may be prudent to evaluate pesticide exposure as a potential risk factor for ADHD. Furthermore, these mice represent a novel animal model to test therapies for ADHD and provide insight into the basic mechanisms underlying this disorder. Here, the investigators propose three Specific Aims to investigate mechanisms underlying the effects of deltamethrin on the dopamine system and characterize the behavioral effects of developmental deltamethrin expsoure. The investigators will then use this information to exploit this novel model to identify molecular targets for therapeutic intervention in ADHD.
描述(由申请人提供):
注意缺陷多动症(ADHD)是一种临床上异质性疾病,其特征是冲动性,多动症和注意力缺陷的核心特征。估计多动症会影响8-12%
全球学龄儿童。 ADHD是一种具有重要遗传贡献的复杂疾病。
但是,尚无单一基因与大量病例有关,表明
环境因素或基因环境相互作用可能有助于病因或临床
多动症的表现。多巴胺转运蛋白(DAT)多态性和DAT的表达升高在ADHD患者中,表明DAT级别的改变可能会导致多动症。由于已经证明环境因素(例如农药)会改变DAT表达,因此我们假设在子宫内,农药暴露可能有助于多动症的发病率或严重性。该实验室的最新数据表明,发育过程中暴露于拟除虫菊酯农药三甲蛋白的小鼠的后代表现出与ADHD儿童相似的症状,包括DAT水平升高,多动症,对精神匹配剂,行为缺陷,行为缺陷,男性性别差异的矛盾平静反应。重要的是,引起这些作用的剂量在EPA为Deltamethrin建立的无观察不良效应水平(NOAEL)下方。这尤其值得注意,因为EPA在制定农药的监管决定时使用的NOAEL。 由于孕妇暴露于拟除虫菊酯和拟除虫菊酯的使用情况下,在过去的十年中使用了急剧增加,因此将农药暴露作为多动症的潜在危险因素可能是审慎的。此外,这些小鼠代表了一种新型的动物模型,用于测试多动症的疗法,并洞悉该疾病的基本机制。在这里,研究人员提出了三个具体旨在研究三分之一对多巴胺系统影响的机制,并表征了发育二甲素体验的行为效应。然后,研究人员将使用此信息来利用这种新型模型来识别ADHD治疗干预的分子靶标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jason R Richardson其他文献
Jason R Richardson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jason R Richardson', 18)}}的其他基金
Microglial Hv1 Proton Channel as a Mediator of Environmentally-Induced Neuroinflammation and Neurodegeneration
小胶质细胞 Hv1 质子通道作为环境诱发的神经炎症和神经变性的介质
- 批准号:
10714415 - 财政年份:2022
- 资助金额:
$ 55.77万 - 项目类别:
Microglial Hv1 Proton Channel as a Mediator of Environmentally-Induced Neuroinflammation and Neurodegeneration
小胶质细胞 Hv1 质子通道作为环境诱发的神经炎症和神经变性的介质
- 批准号:
10584577 - 财政年份:2022
- 资助金额:
$ 55.77万 - 项目类别:
Microglial Hv1 Proton Channel as a Mediator of Environmentally-Induced Neuroinflammation and Neurodegeneration
小胶质细胞 Hv1 质子通道作为环境诱发的神经炎症和神经变性的介质
- 批准号:
10391980 - 财政年份:2022
- 资助金额:
$ 55.77万 - 项目类别:
Health Disparities in Alzheimers and Related Diseases
阿尔茨海默病和相关疾病的健康差异
- 批准号:
10459366 - 财政年份:2020
- 资助金额:
$ 55.77万 - 项目类别:
Health Disparities in Alzheimers and Related Diseases
阿尔茨海默病和相关疾病的健康差异
- 批准号:
10238143 - 财政年份:2020
- 资助金额:
$ 55.77万 - 项目类别:
Health Disparities in Alzheimers and Related Diseases
阿尔茨海默病和相关疾病的健康差异
- 批准号:
10685967 - 财政年份:2020
- 资助金额:
$ 55.77万 - 项目类别:
Mechanism of Gene Environment Interactions in Alzheimer's Disease
阿尔茨海默病基因环境相互作用的机制
- 批准号:
9978067 - 财政年份:2018
- 资助金额:
$ 55.77万 - 项目类别:
Mechanism of Gene Environment Interactions in Alzheimer's Disease
阿尔茨海默病基因环境相互作用的机制
- 批准号:
9302779 - 财政年份:2016
- 资助金额:
$ 55.77万 - 项目类别:
Mechanisms of Pesticide-Induced Neurobehavioral Deficits: Relevance to ADHD
农药引起的神经行为缺陷的机制:与多动症的相关性
- 批准号:
7900822 - 财政年份:2009
- 资助金额:
$ 55.77万 - 项目类别:
Mechanisms of Pesticide-Induced Neurobehavioral Deficits: Relevance to ADHD
农药引起的神经行为缺陷的机制:与多动症的相关性
- 批准号:
8720193 - 财政年份:2007
- 资助金额:
$ 55.77万 - 项目类别:
相似国自然基金
腹侧被盖区多巴胺神经元投射偏向性对甲基苯丙胺自给药个体差异的影响及其机制
- 批准号:32300846
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
社会等级对大鼠甲基苯丙胺成瘾易感性的影响与机制研究
- 批准号:82271537
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
运用Cre转基因小鼠及病毒调控技术研究BDNF-TrkB通路介导的海马神经发生对甲基苯丙胺成瘾记忆的影响及机制
- 批准号:82204373
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
运用Cre转基因小鼠及病毒调控技术研究BDNF-TrkB通路介导的海马神经发生对甲基苯丙胺成瘾记忆的影响及机制
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
重复经颅磁刺激对甲基苯丙胺依赖者皮层环路突触可塑性的影响
- 批准号:81801319
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Ghrelin Deacylase as a Treatment for Opioid Polysubstance Abuse
生长素释放肽脱酰酶治疗阿片类多物质滥用
- 批准号:
10510245 - 财政年份:2022
- 资助金额:
$ 55.77万 - 项目类别:
Definitive Preclinical Studies of Hydrolase Gene Transfer to Treat Cocaine Abuse
水解酶基因转移治疗可卡因滥用的明确临床前研究
- 批准号:
10000864 - 财政年份:2016
- 资助金额:
$ 55.77万 - 项目类别:
Definitive Preclinical Studies of Hydrolase Gene Transfer to Treat Cocaine Abuse
水解酶基因转移治疗可卡因滥用的明确临床前研究
- 批准号:
10241314 - 财政年份:2016
- 资助金额:
$ 55.77万 - 项目类别:
Bath Salts & the Illicit Drug Market: Use, Violence & Health Consequences
浴盐
- 批准号:
9296099 - 财政年份:2014
- 资助金额:
$ 55.77万 - 项目类别: